Related Experiment Videos
p300 modulates nuclear morphology in prostate cancer
Jose D Debes1, Thomas J Sebo, Hannelore V Heemers
1Department of Urology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Cancer Research
|February 12, 2005
Summary
The transcriptional co-activator p300 influences prostate cancer cell structure, altering nuclear morphometry. This finding links p300 to cancer progression and provides new insights into nuclear regulation.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Cellular Morphology
Background:
- Nuclear structure alterations are hallmarks of cancer cells.
- Quantitative nuclear morphometry, using digital image analysis, provides measurable nuclear features.
- Previous studies linked quantitative nuclear morphometry to prostate cancer metastasis and recurrence, but underlying mechanisms were unclear.
Purpose of the Study:
- To investigate the cellular mechanisms behind nuclear morphometric changes in prostate cancer.
- To explore the role of the transcriptional co-activator p300 in modulating nuclear morphology.
- To determine if p300 expression correlates with quantifiable nuclear alterations and aggressive features in prostate cancer.
Main Methods:
- Analysis of p300 expression in prostate cancer biopsy tissues from 95 patients.
- Digital image analysis of nuclear morphometry (e.g., diameter, perimeter, absorbance) in cultured prostate cancer cells transfected with p300.
- Correlation of nuclear alterations with prostate cancer aggressiveness markers (Ki-67, extraprostatic extension).
- Measurement of mRNA and protein levels of nuclear matrix peptides (lamins A and C) after p300 transfection.
Main Results:
- p300 expression in patient biopsies correlated with quantifiable nuclear alterations.
- p300 transfection in prostate cancer cells induced significant changes in nuclear morphology.
- Induced nuclear alterations correlated with aggressive cancer features.
- p300 transfection specifically increased levels of lamins A and C, suggesting their role in mediating these effects.
Conclusions:
- The transcriptional co-activator p300 plays a significant role in regulating nuclear morphology in prostate cancer.
- p300-induced nuclear alterations are linked to prostate cancer progression and aggressiveness.
- Lamins A and C appear to mediate the effects of p300 on nuclear structure.
- This study reveals a novel link between transcriptional regulation and structural changes in prostate cancer cells.